Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2009-6-9
pubmed:abstractText
Mast cells are found in the brain, where they contribute to immune responses. They have been implicated in multiple sclerosis, but their potential role in Alzheimers disease (AD), another inflammatory disease of the central nervous system, remains elusive. In the present study, we examined mast cell responses to amyloid beta (Abeta) peptides 1-40 and 1-42, the major components of the Alzheimer amyloid plaques. Rat peritoneal mast cells were used as experimental model for human brain serosal mast cells. Fibrillar Abeta1-40 and Ami1-42 peptides induced concentration-dependent exocytosis, as assessed by measurement of histamine secretion; exocytosis was reduced by pre-treatment with pertussis toxin and with antibodies against the CD47 receptor and the beta1-integrin subunit. Fibrillar Abeta1-40 and Abeta1- 42 peptides coated on heat-inactivated yeast particles and soluble fibrillar Abeta1-40 and Abeta1-42 peptides were also recognized and phagocyted by mast cells. Uptake of the peptides was decreased in the presence of 4N1, a peptide agonist of the CD47 receptor, but remained unchanged in the presence of 4NGG, a peptide derived from 4N1 which does not bind to CD47. Non-fibrillar forms of Abeta1-40 and 1-42 peptides were unable to elicit mast cell responses. These results show that fibrillar Abeta peptides can trigger mast cells and elicit exocytosis and phagocytosis. The Abeta-induced activation of mast cells operates through a CD47/beta1-integrin membrane complex coupled with Gi-protein. The present data support the hypothesis that mast cells, similarly to microglial cells, could play a major role in AD pathogenesis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0394-6320
pubmed:author
pubmed:issnType
Print
pubmed:volume
22
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
473-83
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:19505377-Amyloid beta-Peptides, pubmed-meshheading:19505377-Animals, pubmed-meshheading:19505377-Antibodies, pubmed-meshheading:19505377-Antigens, CD29, pubmed-meshheading:19505377-Antigens, CD47, pubmed-meshheading:19505377-Cells, Cultured, pubmed-meshheading:19505377-Exocytosis, pubmed-meshheading:19505377-GTP-Binding Protein alpha Subunits, Gi-Go, pubmed-meshheading:19505377-Histamine Release, pubmed-meshheading:19505377-Humans, pubmed-meshheading:19505377-Male, pubmed-meshheading:19505377-Mast Cells, pubmed-meshheading:19505377-Microscopy, Fluorescence, pubmed-meshheading:19505377-Peptide Fragments, pubmed-meshheading:19505377-Pertussis Toxin, pubmed-meshheading:19505377-Phagocytosis, pubmed-meshheading:19505377-Rats, pubmed-meshheading:19505377-Rats, Wistar, pubmed-meshheading:19505377-Time Factors
pubmed:articleTitle
Amyloid beta peptides trigger CD47-dependent mast cell secretory and phagocytic responses.
pubmed:affiliation
Université de Strasbourg, CNRS UMR 7213, Laboratoire de Biophotonique et Pharmacologie, Faculté de Pharmacie, Illkirch, France. Nathalie.niederhoffer@pharma.u-strasbg.fr
pubmed:publicationType
Journal Article